Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic-Reference-Cited by-同舟云学术

Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic

Published:2021 Issue:19 Volume:9 Page:6584-6596
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Hong Sungchae¹,Ju Sanghyun¹,Yoo Jin-Wook¹,Ha Nam-Chul²,Jung Yunjin¹^ORCID

Affiliation:

1. College of Pharmacy, Pusan National University, Busan, 46241 Republic of Korea

2. Department of Agricultural Biotechnology, Center for Food and Bioconvergence, Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul, 08826 Republic of Korea

Abstract

Colon-targeted cell-permeable IKK-activated GSK3β inhibitory peptide (CTP-IAGIP in a colon-targeted capsule) is an inflammation-responsive anti-colitic therapeutics.

Funder

Ministry of Education

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D1BM00533B

Reference43 articles.

1. Regulation of GSK-3

2. Glycogen synthase kinase 3: more than a namesake

3. Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

4. Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

5. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model;International Journal of Molecular Sciences;2024-07-29

2. A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug;Molecular Pharmaceutics;2022-08-31

3. Dapsone Azo-Linked with Two Mesalazine Moieties Is a “Me-Better” Alternative to Sulfasalazine;Pharmaceutics;2022-03-21

4. Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson’s Disease;International Journal of Molecular Sciences;2022-01-17